How Britain decides which drugs to buy
The Evolving Landscape of Drug Cost Evaluation in the UK As the world grapples with soaring healthcare costs, the UK’s National Institute for Health and Care Excellence (NICE) remains at the forefront of ensuring that the financial burden of new drugs does not outweigh their benefits. The recent case surrounding Brineura, an enzyme therapy for … Read more